Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) deadline 2026
The current listed application deadline is July 9, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.
Application Countdown
Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.
Quick facts
- Opportunity number
- Not listed
- Last updated
- May 3, 2026
- Expected awards
- Not listed
Deadline summary
This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and regenerative medicine (TE/RM). APEx will be composed of Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) in the area of therapeutics...
Key dates
Before you apply
Eligibility snapshot
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.